XML 19 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Operating Activities    
Net loss $ (17,333) $ (5,302)
Net loss from discontinued operations 0 (1,267)
Loss from continuing operations (17,333) (4,035)
Adjustments to reconcile net loss from continuing operations to net cash provided by (used in) operating activities:    
Depreciation 868 368
Amortization 687 1,085
Non cash amortization of right-of-use asset and liability 225 0
Provision for excess and obsolete inventories 1,782 682
Charge for lower of cost or net realizable value inventories 60 656
Impairment of right-of-use asset 660 0
Impairment of intangibles including goodwill 8,714 0
Gain on disposal of property and equipment (133) (251)
Share based compensation expense 574 199
Income from equity method investment (41) (136)
Changes in operating assets and liabilities    
Accounts receivable, net of change in allowance 859 (1,419)
Unbilled revenue 2,101 (2,253)
Income tax refund receivable\payable (1,262) 158
Inventories 27 (1,591)
Prepaid expenses and other current assets (147) (206)
Other assets (2) 1
Accounts payable (1,259) 180
Accrued expenses (220) 477
Deferred revenue 16 98
Net cash used in operating activities – continuing operations (3,824) (5,987)
Net cash provided by operating activities – discontinued operations 0 1,180
Net cash used in operating activities (3,824) (4,807)
Investing Activities    
Proceeds from promissory note receivable 2,600 0
Acquisition of net operating assets 0 (1,264)
Proceeds from sale of business 0 753
Loan repayments from equity method investee 41 185
Purchases of property and equipment (608) (602)
Disposals of property and equipment 361 452
Net cash provided by (used in) investing activities – continuing operations 2,394 (476)
Net cash provided by investing activities – discontinued operations 0 7,075
Net cash provided by investing activities 2,394 6,599
Financing Activities    
Change in bank revolving line of credit 2,800 (500)
Proceeds from notes payable 6,372 0
Proceeds from share issuances and exercise of stock options 2,315 0
Payments on debt (3,278) (2,228)
Net cash provided by (used in) financing activities – continuing operations 8,209 (2,728)
Net cash used in financing activities – discontinued operations 0 (598)
Net cash provided by (used in) financing activities 8,209 (3,326)
Net increase (decrease) in cash and cash equivalents and restricted cash 6,779 (1,534)
Cash and cash equivalents and restricted cash at beginning of year 1,595 3,129
Cash and cash equivalents and restricted cash at end of year $ 8,374 $ 1,595